Hydroxychloroquine synergizes with the PI3K inhibitor BKM120 to exhibit antitumor efficacy independent of autophagy
Abstract Background The critical role of phosphoinositide 3-kinase (PI3K) activation in tumor cell biology has prompted massive efforts to develop PI3K inhibitors (PI3Kis) for cancer therapy. However, recent results from clinical trials have shown only a modest therapeutic efficacy of single-agent P...
Guardado en:
Autores principales: | Xin Peng, Shaolu Zhang, Wenhui Jiao, Zhenxing Zhong, Yuqi Yang, Francois X. Claret, Moshe Elkabets, Feng Wang, Ran Wang, Yuxu Zhong, Zhe-Sheng Chen, Dexin Kong |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/46925260bbed4e66aa320b5ae39a76b7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Türk Yapım Şirketlerinin Görsel Kimlik Bağlamında İncelenmesi: BKM Örneği
por: Özer Silsüpür, et al.
Publicado: (2021) -
Somatotype, the risk of hydroxychloroquine retinopathy, and safe daily dosing guidelines
por: Browning DJ, et al.
Publicado: (2018) -
Non-synaptic Cell-Autonomous Mechanisms Underlie Neuronal Hyperactivity in a Genetic Model of PIK3CA-Driven Intractable Epilepsy
por: Achira Roy, et al.
Publicado: (2021) -
Coding patterns used by ophthalmologists for hydroxychloroquine retinal toxicity
por: Chiu SY, et al.
Publicado: (2018) -
Incidence of and risk factors for chloroquine and hydroxychloroquine retinopathy in Thai rheumatologic patients
por: Tangtavorn N, et al.
Publicado: (2016)